日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Contrast-Enhanced Ultrasound with VEGFR2-Targeted Microbubbles for Monitoring Regorafenib Therapy Effects in Experimental Colorectal Adenocarcinomas in Rats with DCE-MRI and Immunohistochemical Validation

对比增强超声结合 VEGFR2 靶向微泡监测瑞戈非尼对大鼠实验性结直肠腺癌的治疗效果,并通过 DCE-MRI 和免疫组织化学验证

Ralf Stefan Eschbach, Dirk-Andre Clevert, Heidrun Hirner-Eppeneder, Michael Ingrisch, Matthias Moser, Jessica Schuster, Dina Tadros, Moritz Schneider, Philipp Maximilian Kazmierczak, Maximilian Reiser, Clemens C Cyran

Correlation of perfusion MRI and 18F-FDG PET imaging biomarkers for monitoring regorafenib therapy in experimental colon carcinomas with immunohistochemical validation

灌注 MRI 与 18F-FDG PET 成像生物标志物在实验性结肠癌中监测瑞戈非尼治疗的相关性及免疫组织化学验证

Ralf S Eschbach, Wolfgang P Fendler, Philipp M Kazmierczak, Marcus Hacker, Axel Rominger, Janette Carlsen, Heidrun Hirner-Eppeneder, Jessica Schuster, Matthias Moser, Lukas Havla, Moritz J Schneider, Michael Ingrisch, Lukas Spaeth, Maximilian F Reiser, Konstantin Nikolaou, Clemens C Cyran